Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-tracer Multiparametric PET Imaging
NCT06014515Phase 1Recruiting
- Sponsor
- University of California, Davis
- Start
- Feb 2024
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fludeoxyglucose f 18, sponsored by University of California, Davis. Primary endpoint: Blood Flow. Started Feb 2024; status: recruiting.
02
Drugs
fludeoxyglucose f 18
Beyond the preview
Go deeper on NCT06014515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06014515.